ESAIY Stock Price, Chart, Stats & News
Eisai Co., Ltd. (ESAIY) is a dividend-paying stock with a current dividend yield of 9.53% as of Oct 21, 2026. It pays $0.7549 per share over the trailing twelve months. Its dividend has grown at a -12.43% 5-year compound annual rate.
Dividend safety
ESAIY pays out about 326% of earnings, leaving little safety margin.
ESAIY chart
About
Eisai Co., Ltd. is a Japanese pharmaceutical firm deeply involved in the entire lifecycle of drug development, from initial research and innovation to manufacturing, distribution, and international trade within Japan. Its comprehensive product portfolio includes prominent medications such as Dayvigo, prescribed for insomnia, and the potent anticancer drug Lenvima, a molecularly targeted therapy effective against thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma when paired with everolimus. The company also markets Methycobal for peripheral neuropathy and Halaven, another anticancer agent targeting breast cancer.
Similar securities
Based on sector and market capitalization
